Clinical Trial Update: Understanding Immunity Persistence After Adolescent MenC Vaccination

View source ↗

Summary

A completed study evaluating persistence of antibodies after an adolescent booster dose of the meningococcal group C vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Meningococcal Group C vaccine (Meningococcal group C vaccine)

Snippet

Sponsor: University of Oxford | Conditions: Antibody Persistance After Booster Dose of Men C Vaccine | Status: COMPLETED